DJIA 18,041.54 -190.48 -1.04%
NASDAQ 5,032.75 -56.61 -1.11%
S&P 500 2,104.20 -21.86 -1.03%
market minute promo

2.16 -0.02 (-0.92%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PLX $2.16 -0.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.13
Previous Close $2.18
Daily Range $2.11 - $2.16
52-Week Range $1.53 - $4.20
Market Cap $202.2M
P/E Ratio -6.41
Dividend (Yield) $0.00 (0.0%)
Volume 164,604
Average Daily Volume 295,572
Current FY EPS -$0.32

Sector

Healthcare

Industry

Drug Makers

Protalix BioTherapeutics, Inc. (PLX) Description

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system. Website: http://www.protalix.com/

News & Commentary Rss Feed

3 High-Risk, High-Reward Biotech Stocks for Long Term Investors

Everyone wants to get rich, but investing in the wrong developmental companies can have disastrous consequences. Here are three companies with game-changing potential that have yet to hit their stride -- and may payoff in the long run.

Can Protalix BioTherapeutics Deliver?

Surging Earnings Estimates Signal Good News for Protalix BioTherapeutics (PLX) - Tale of the Tape

Protalix BioTherapeutics (PLX) Shares March Higher, Can It Continue? - Tale of the Tape

Protalix BioTherapeutics (PLX) Shares March Higher, Can It Continue? - Tale of the Tape

Why Protalix BioTherapeutics (PLX) Stock Might be a Great Pick - Tale of the Tape

Protalix BioTherapeutics (PLX): An Off-the-Radar Potential Winner - Tale of the Tape

Protalix BioTherapeutics (PLX): An Off-the-Radar Potential Winner - Tale of the Tape

Health Care Sector Update for 02/12/2015: PLX, THLD, ACOR

Protalix Finishes Patient Enrollment for Fabry Disease Study - Analyst Blog

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday Morning

Protalix BioTherapeutics, Inc. (PLX) Jumps: Stock Rises 16% - Tale of the Tape

See More PLX News...

PLX's Top Competitors

PLX $2.16 (-0.92%)
Current stock: PLX
AMGN $159.01 (-2.79%)
Current stock: AMGN
GILD $109.77 (-1.74%)
Current stock: GILD
BIIB $392.88 (-1.45%)
Current stock: BIIB